Gordon Meiklejohn

3.1k total citations · 1 hit paper
53 papers, 1.6k citations indexed

About

Gordon Meiklejohn is a scholar working on Epidemiology, Infectious Diseases and Genetics. According to data from OpenAlex, Gordon Meiklejohn has authored 53 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Epidemiology, 15 papers in Infectious Diseases and 7 papers in Genetics. Recurrent topics in Gordon Meiklejohn's work include Influenza Virus Research Studies (27 papers), Respiratory viral infections research (21 papers) and Viral gastroenteritis research and epidemiology (7 papers). Gordon Meiklejohn is often cited by papers focused on Influenza Virus Research Studies (27 papers), Respiratory viral infections research (21 papers) and Viral gastroenteritis research and epidemiology (7 papers). Gordon Meiklejohn collaborates with scholars based in United States, Japan and Chile. Gordon Meiklejohn's co-authors include M Minamitani, Otto F. Sieber, Vincent A. Fulginiti, Jerry J. Eller, Theodore C. Eickhoff, Myron J. Levin, H Grant Stiver, Jessie R. Groothuis, Brian A. Lauer and Gerard P. Rabalais and has published in prestigious journals such as New England Journal of Medicine, JAMA and Annals of Internal Medicine.

In The Last Decade

Gordon Meiklejohn

50 papers receiving 1.4k citations

Hit Papers

RESPIRATORY VIRUS IMMUNIZATION 1969 2026 1988 2007 1969 100 200 300 400

Peers

Gordon Meiklejohn
T. R. Cate United States
Mary L. Kumar United States
Kenneth L. Herrmann United States
Marie Ogilvie United Kingdom
A. A. McLean United States
D. Westmoreland United Kingdom
Laura T. Gutman United States
Allen Izu United States
Robert E. Weibel United States
T. R. Cate United States
Gordon Meiklejohn
Citations per year, relative to Gordon Meiklejohn Gordon Meiklejohn (= 1×) peers T. R. Cate

Countries citing papers authored by Gordon Meiklejohn

Since Specialization
Citations

This map shows the geographic impact of Gordon Meiklejohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon Meiklejohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon Meiklejohn more than expected).

Fields of papers citing papers by Gordon Meiklejohn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon Meiklejohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon Meiklejohn. The network helps show where Gordon Meiklejohn may publish in the future.

Co-authorship network of co-authors of Gordon Meiklejohn

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon Meiklejohn. A scholar is included among the top collaborators of Gordon Meiklejohn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon Meiklejohn. Gordon Meiklejohn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Janoff, Edward N., James O'Brien, Peter J. Thompson, et al.. (1993). Streptococcus pneumoniae Colonization, Bacteremia, and Immune Response among Persons with Human Immunodeficiency Virus Infection. The Journal of Infectious Diseases. 167(1). 49–56. 101 indexed citations
2.
Nerome, K., et al.. (1992). INFLUENZA ACTIVITY - UNITED-STATES AND WORLDWIDE - COMPOSITION OF THE 1992-1993 INFLUENZA VACCINE (REPRINTED FROM MMWR, VOL 41, PG 315-323, 1992). JAMA. 267(20). 2727–2728. 2 indexed citations
3.
Bucher, Doris J., А. Михаил, Patricia M. Graves, et al.. (1991). Rapid detection of type A influenza viruses with monoclonal antibodies to the M protein (M1) by enzyme-linked immunosorbent assay and time-resolved fluoroimmunoassay. Journal of Clinical Microbiology. 29(11). 2484–2488. 24 indexed citations
4.
Groothuis, Jessie R., Gordon Meiklejohn, Brian A. Lauer, Myron J. Levin, & Gerard P. Rabalais. (1991). Immunization of High-Risk Infants Younger Than 18 Months of Age with Split-Product Influenza Vaccine. PEDIATRICS. 87(6). 823–828. 103 indexed citations
5.
Meiklejohn, Gordon, et al.. (1989). Treatment of an Influenza A Outbreak in a Teaching Nursing Home. Journal of the American Geriatrics Society. 37(3). 210–218. 34 indexed citations
6.
Meiklejohn, Gordon, et al.. (1989). Effectiveness of Influenza Vaccine When Given During an Outbreak of Influenza A/H3N2 in a Nursing Home. Journal of the American Geriatrics Society. 37(5). 407–410. 32 indexed citations
7.
Meiklejohn, Gordon, et al.. (1988). Antibody Response of an Elderly Population to a Supplemental Dose of Influenza B Vaccine. Journal of the American Geriatrics Society. 36(7). 593–599. 36 indexed citations
8.
Yanagihara, Richard, W. Paul Glezen, A. R. Diwan, et al.. (1985). Serological Evidence of Hantaan Virus Infection in the United States. American Journal of Tropical Medicine and Hygiene. 34(2). 396–399. 14 indexed citations
9.
Burlington, D. Bruce, Gordon Meiklejohn, & Steven R. Mostow. (1982). Anti-influenza A virus activity of amantadine hydrochloride and rimantadine hydrochloride in ferret tracheal ciliated epithelium. Antimicrobial Agents and Chemotherapy. 21(5). 794–799. 13 indexed citations
10.
Halsey, Neal A., et al.. (1980). An epidemic of Reye syndrome associated with influenza A (H1N1) in Colorado. The Journal of Pediatrics. 97(4). 535–539. 9 indexed citations
11.
Meiklejohn, Gordon, Theodore C. Eickhoff, & Patricia M. Graves. (1977). Antibody Response of Young Adults to Experimental Influenza A/ New Jersey/76 Virus Vaccines. The Journal of Infectious Diseases. 136(Supplement 3). S456–S459. 7 indexed citations
12.
Meiklejohn, Gordon. (1973). Control of Smallpox and Influenza. The Journal of Infectious Diseases. 127(2). 215–219. 3 indexed citations
13.
Eickhoff, Theodore C. & Gordon Meiklejohn. (1969). Protection against Hong Kong influneza by adjuvant vaccine containing A2-Ann Arbor-67.. PubMed. 41(3). 562–3. 18 indexed citations
14.
Meiklejohn, Gordon. (1962). Adjuvant Influenza Adenovirus Vaccine. JAMA. 179(8). 594–594. 20 indexed citations
15.
Meiklejohn, Gordon, et al.. (1961). Air sampling to recover variola virus in the environment of a smallpox hospital.. PubMed. 25. 63–7. 23 indexed citations
16.
Downie, A. W., et al.. (1961). Studies on the virus content of mouth washings in the acute phase of smallpox.. PubMed. 25. 49–53. 21 indexed citations
17.
Meiklejohn, Gordon. (1960). OBSERVATIONS ON LIVE INFLUENZA VACCINE. Journal of the American Medical Association. 172(13). 1354–1354. 10 indexed citations
18.
Meiklejohn, Gordon. (1958). EFFECTIVENESS OF MONOVALENT INFLUENZA A-PRIME VACCINE DURING 1957 INFLUENZA A-PRIME EPIDEMIC12. American Journal of Epidemiology. 67(2). 237–249. 9 indexed citations
19.
Meiklejohn, Gordon, et al.. (1952). Propagation of Dengue Virus Strains in Unweaned Mice. American Journal of Tropical Medicine and Hygiene. 1(1). 51–58. 26 indexed citations
20.
Meiklejohn, Gordon, et al.. (1952). Adaptation of Dengue Virus to the Hamster. American Journal of Tropical Medicine and Hygiene. 1(1). 59–65. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026